Sign up to save your podcasts
Or
Share Unlocking CSU pathogenesis to shape the future treatment landscape
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Unlocking CSU pathogenesis to shape the future treatment landscape
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.
The experts:
- Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/
View all episodes
By touchpodcasttouchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.
The experts:
- Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/